U. Jehn
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Transplantation top 2%
Papers in
- Hematology 51
- Acute Myeloid Leukemia Research 42
- Hematopoietic Stem Cell Transplantation 20
- Chronic Myeloid Leukemia Treatments 7
-
- Renal Transplantation Outcomes and Treatments 11
- Co-authors
- Volker HeinemannStefan SuciuTomas LindahlGunnar BjursellAlice AdamsChristine Kaschka‐DierichGeorg W. BornkammBob Löwenberg
- Journals
- Blood (11 papers)Journal of Molecular Medicine (10 papers)Journal of Clinical Medicine (8 papers)Annals of Hematology (8 papers)Scientific Reports (5 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
U. Jehn
121 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 105
- Hematology 1.1k
- Transplantation 197
- Oncology 827
- Genetics 319
- Infectious Diseases 498
Countries citing papers authored by U. Jehn
This map shows the geographic impact of U. Jehn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Jehn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Jehn more than expected).
Fields of papers citing papers by U. Jehn
This network shows the impact of papers produced by U. Jehn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Jehn. The network helps show where U. Jehn may publish in the future.
Co-authors
The 25 scholars most cited alongside U. Jehn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 4 | |
| 3 | 2022 | 1 | |
| 4 | 2022 | 3 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 1 | |
| 7 | 2021 | 12 | |
| 8 | 2020 | 3 | |
| 9 | 2020 | 1 | |
| 10 | 2019 | 10 | |
| 11 | Allogeneic vs autologous stem cell transplantation according to cytogenetic and FAB features in AML patients (pts) <=45 yrs old in CRI: Results of the EORTC-GIMEMA AML-10 trial | 2002 | 2 |
| 12 | Allogeneic vs autologous stem cell transplantation according to cytogenetic features in AML patients (pts) <= 45 yrs old in first CR: Results of the EORTC-GIMEMA AML-10 trial | 2001 | 5 |
| 13 | The type of anthracycline administered during remission induction and consolidation therapy of AML has an impact on feasibility of subsequent autologous or allogeneic transplantation and induced marrow toxicity: preliminary results of the EORTC-Gimema AML-10 randomized trial. | 2000 | 5 |
| 14 | 1998 | 206 | |
| 15 | [Leukemias in advanced age. Part 2: Myelodysplastic syndrome and chronic leukemia]. | 1994 | 0 |
| 16 | Exogenous interleukin 2 (IL 2) reconstitutes deficient in vitro T-cell growth of patients with chronic lymphocytic leukemia of B-cell lineage (B-CLL). | 1990 | 1 |
| 17 | Recurrence of a Wilms' tumor nine years after first diagnosis | 1988 | 1 |
| 18 | 1988 | 5 | |
| 19 | 1985 | 1 | |
| 20 | 1985 | 2 |
About U. Jehn
U. Jehn is a scholar working on Hematology, Transplantation, Genetics, Occupational Therapy and Oncology, having authored 125 papers that have together received 2.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (42 papers), Acute Lymphoblastic Leukemia research (22 papers), Hematopoietic Stem Cell Transplantation (20 papers), Neutropenia and Cancer Infections (16 papers), Chronic Lymphocytic Leukemia Research (15 papers), Renal Transplantation Outcomes and Treatments (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and Chronic Myeloid Leukemia Treatments (7 papers). The work is most often cited by research in Hematology (1.1k citations), Transplantation (197 citations), Oncology (827 citations), Genetics (319 citations) and Infectious Diseases (498 citations). U. Jehn has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Volker Heinemann, Stefan Suciu, Tomas Lindahl, Gunnar Bjursell, Alice Adams, Christine Kaschka‐Dierich, Georg W. Bornkamm, Bob Löwenberg, R Zittoun and M. Peetermans. Their work appears in journals such as Blood, Journal of Molecular Medicine, Journal of Clinical Medicine, Annals of Hematology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.